OR WAIT null SECS
ERT announced that following its early Q2 merger with Bioclinica, the combined company is renamed Clario. Clario is a technology company that generates clinical evidence by fusing scientific knowledge and global scale into the endpoint technology platform.
Only Clario can deliver Trial Anywhere, the ability to execute decentralized, hybrid and site-based clinical trials by deploying technology while maintaining the precision and reliability of evidence.
Since 1990, Clario has completed more than 19,000 clinical trials and contributed to 870 regulatory approvals. Between 2019 and 2020 alone, Clario supported 70% of all Federal and Drug Administration (FDA) approvals.